IT201700083044A1 - “uso della gelsolina come marcatore diagnostico e prognostico delle malattie infiammatorie intestinali” - Google Patents

“uso della gelsolina come marcatore diagnostico e prognostico delle malattie infiammatorie intestinali”

Info

Publication number
IT201700083044A1
IT201700083044A1 IT102017000083044A IT201700083044A IT201700083044A1 IT 201700083044 A1 IT201700083044 A1 IT 201700083044A1 IT 102017000083044 A IT102017000083044 A IT 102017000083044A IT 201700083044 A IT201700083044 A IT 201700083044A IT 201700083044 A1 IT201700083044 A1 IT 201700083044A1
Authority
IT
Italy
Prior art keywords
gelsolina
diagnostic
inflammatory diseases
prognostic marker
intestinal inflammatory
Prior art date
Application number
IT102017000083044A
Other languages
English (en)
Inventor
Laura Stronati
Roberta Vitali
Salvatore Cucchiara
Original Assignee
Laura Stronati
Roberta Vitali
Salvatore Cucchiara
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laura Stronati, Roberta Vitali, Salvatore Cucchiara filed Critical Laura Stronati
Priority to IT102017000083044A priority Critical patent/IT201700083044A1/it
Priority to PCT/IB2018/055385 priority patent/WO2019016753A1/en
Publication of IT201700083044A1 publication Critical patent/IT201700083044A1/it

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IT102017000083044A 2017-07-20 2017-07-20 “uso della gelsolina come marcatore diagnostico e prognostico delle malattie infiammatorie intestinali” IT201700083044A1 (it)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IT102017000083044A IT201700083044A1 (it) 2017-07-20 2017-07-20 “uso della gelsolina come marcatore diagnostico e prognostico delle malattie infiammatorie intestinali”
PCT/IB2018/055385 WO2019016753A1 (en) 2017-07-20 2018-07-19 USE OF GELSOLIN AS A DIAGNOSTIC AND PROGNOSTIC MARKER OF INTESTINAL INFLAMMATORY DISEASES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102017000083044A IT201700083044A1 (it) 2017-07-20 2017-07-20 “uso della gelsolina come marcatore diagnostico e prognostico delle malattie infiammatorie intestinali”

Publications (1)

Publication Number Publication Date
IT201700083044A1 true IT201700083044A1 (it) 2019-01-20

Family

ID=60990953

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102017000083044A IT201700083044A1 (it) 2017-07-20 2017-07-20 “uso della gelsolina come marcatore diagnostico e prognostico delle malattie infiammatorie intestinali”

Country Status (2)

Country Link
IT (1) IT201700083044A1 (it)
WO (1) WO2019016753A1 (it)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113917149B (zh) * 2021-09-30 2024-05-24 江苏扬新生物医药有限公司 凝溶胶蛋白检测物在制备子宫癌评估检测试剂中的应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005112970A2 (en) * 2004-05-12 2005-12-01 The Brigham And Women's Hospital, Inc. Use of gelsolin to treat infections
WO2007109056A2 (en) * 2006-03-15 2007-09-27 The Brigham And Women's Hospital, Inc. Use of gelsolin to diagnose and treat inflammatory diseases
WO2008022177A2 (en) * 2006-08-15 2008-02-21 Prometheus Laboratories, Inc. Methods for diagnosing irritable bowel syndrome
AU2013202205A1 (en) * 2006-03-15 2013-05-02 The Brigham And Women's Hospital, Inc. Use of Gelsolin to Diagnose and Treat Inflammatory Disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1406051B1 (it) 2010-08-05 2014-02-06 D M G Italia S R L Uso di hmgb1 come marcatore biologico di infiammazione intestinale umana, metodo non invasivo per la sua rilevazione in campioni fecali e kit relativo.

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005112970A2 (en) * 2004-05-12 2005-12-01 The Brigham And Women's Hospital, Inc. Use of gelsolin to treat infections
WO2007109056A2 (en) * 2006-03-15 2007-09-27 The Brigham And Women's Hospital, Inc. Use of gelsolin to diagnose and treat inflammatory diseases
AU2013202205A1 (en) * 2006-03-15 2013-05-02 The Brigham And Women's Hospital, Inc. Use of Gelsolin to Diagnose and Treat Inflammatory Disease
WO2008022177A2 (en) * 2006-08-15 2008-02-21 Prometheus Laboratories, Inc. Methods for diagnosing irritable bowel syndrome

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
F. WU ET AL: "Differential Expression of Inflammatory and Fibrogenic Genes and Their Regulation by NF- B Inhibition in a Mouse Model of Chronic Colitis", THE JOURNAL OF IMMUNOLOGY, vol. 179, no. 10, 15 November 2007 (2007-11-15), US, pages 6988 - 7000, XP055465981, ISSN: 0022-1767, DOI: 10.4049/jimmunol.179.10.6988 *
PIRJO JUUSELA: "ORAL HEALTH IN HEREDITARY GELSOLIN AMYLOIDOSIS", 8 April 2016 (2016-04-08), XP055465992, Retrieved from the Internet <URL:http://www.suomenamyloidoosiyhdistys.fi/tiedostot/PirjoJuusela2016.pdf> [retrieved on 20180410] *

Also Published As

Publication number Publication date
WO2019016753A1 (en) 2019-01-24

Similar Documents

Publication Publication Date Title
MA52885A (fr) Anticorps anti il-11ra
MA52212A (fr) Anticorps multivalent
MA52152A (fr) Anticorps
JP1733839S (ja) 医療用支柱アッセンブリ
FR3017298B1 (fr) Conjugues et pro-drogues pour le traitement du cancer et de maladies inflammatoires
CO2019013718A2 (es) Anticuerpos anti-trkb
DK3580567T3 (da) I vitro-fremgangsmåde til diagnose af lungkræft
MA55882A (fr) Spéculum vaginal
JP1709667S (ja) 医療用検査キット
IT201700083044A1 (it) “uso della gelsolina come marcatore diagnostico e prognostico delle malattie infiammatorie intestinali”
MA54097A (fr) Anticorps anti-fn14 humain
IT201700083055A1 (it) “uso della proteina inibitore 2 della dissociazione di rho gdp come marcatore diagnostico e prognostico delle malattie infiammatorie intestinali”
IT201700111939A1 (it) Composizione farmaceutica per l’uso nel trattamento di stati infiammatori
DK3996688T3 (da) Farmaceutisk præparat
DK3702106T3 (da) Manchetfastgørelsesindretning
CL2018003011S1 (es) Instrumento de medición
MA45387A (fr) Compositions comprenant du timolol et un agent anti-inflammatoire
IT201700045856A1 (it) Kit di determinazione della recettivita’ endometriale
ES1249535Y (es) Bastón medidor de distancia
DK4167962T3 (da) Lavementformulering
UA41524S (uk) Рулетка вимірювальна
UA41914S (uk) Рулетка вимірювальна
UA42035S (uk) Рулетка вимірювальна
UA41516S (uk) Рулетка вимірювальна
UA42052S (uk) Рулетка вимірювальна